Kadalayil et al, Air purifiers improve rhinitis quality of life and perception of sleep quality in asthma patients

 

Table S1. Questions on sleep quality within the rhinitis quality of life questionnaire (RQLQ)

How troubled have you been by each of these sleep problems during the last week as a result of your nose/eye symptoms?

Questions

Not troubled

Hardly troubled

Somewhat troubled

Moderately troubled

Quite a bit troubled

Very troubled

Extremely troubled

1. Difficulty getting to sleep

0

1

2

3

4

5

6

2. Wake up during night

0

1

2

3

4

5

6

3. Lack of good night’s sleep

0

1

2

3

4

5

6

 

Table S2. Air quality, rhinitis, aeroallergen sensitisation, asthma control, and asthma and rhinitis quality of life at baseline in the ITT population

 

Placebo (dummy filter)

N=25

Intervention (active filter)

N=25

P-value

 

mean ± SD

Particulate matter (PM2.5, μg/m3)

[median (IQR)] §

5.60 (2.99, 13.30)

3.28 (0.49, 8.66)

0.089

Rhinitis (Yes), n (%)

76% (19/25)

80% (20/25)

0.733

Aeroallergen sensitisation (Yes) (n (%) ¥

84% (21/25)

72% (18/25)

0.306

Juniper Asthma control questionnaire-6 (ACQ6) scores

2.26 ± 0.85

2.41 ± 0.67

0.483

Juniper asthma quality of life questionnaire (AQLQ) scores

5.21 ± 0.91

5.58 ± 0.89

0.150

Juniper rhinitis quality of life questionnaire (RQLQ) scores

42.16 ± 29.70

33.24 ± 32.01

0.312

ITT: intention-to-treat; SD: standard deviation; IQR: interquartile range; mean ± SD unless otherwise specified. §Medians (IQR) for highly skewed data; N=23; ¥ Sensitisation to any of house dust mite, grass, tree pollen, Alternaria, Aspergillus, Penicillium, dander from pets or feather.

 

Table S3. Comparing the rhinitis quality of life questionnaire (RQLQ) of placebo and intervention groups using multivariable regression analysis.

Variables

Coefficient (95% CI)

P-value

BMI

1.38 (0.01, 2.75)

0.049

Household smokes (Y vs N)

23.66 (1.70, 45.63)

0.035

Groups (Intervention vs Placebo) §

-16.64 (-32.04, -1.23)

0.034

RQLQ scores of the intervention group (Dyson purifiers with active HEPA filters) was compared to that of the placebo group (with dummy filters) using multivariable repeated measures analyses (random intercept models). The analyses included a total of 550 data points collected from 25 participants from each of the groups who were followed up 11 times during the study to collect RQLQ data. Three subjects from the intervention group and two from the placebo group had missing score values for some visits resulting in 537 data points in the repeated measures analysis for the final model. The risk factors independently associated with RQLQ as identified in a stepwise backward elimination procedure starting from a fully adjusted model with 22 potential risk factors

Coefficient: regression coefficient; CI: confidence intervals; BMI: body mass index; RQLQ: Juniper rhinitis quality of life questionnaire

Coefficients presented are for the intervention group compared to the placebo group.

  • Negative coefficient (reduction in RQLQ scores) indicates better rhinitis quality of life in Intervention.

 

Table S4. Linear regression analysis of sleep scores using longitudinal sleep data

Questions

N

Coefficient (95% CI)§

P-value

 

Placebo

Intervention

 

 

1. Difficulty getting to sleep

25

25

-0.79 (-1.39, -0.20)

0.009

2. Wake up during night

25

25

-0.67 (-1.26, -0.08)

0.026

3. Lack of good night’s sleep

25

25

-0.63 (-1.31, 0.05)

0.071

Repeated measures regression analysis of sleep data from 11 assessments based on three questions on sleep quality.

There was a total of 538 (out of a possible 550) data points from 50 patients in the regression analyses.

  • Coefficient represents the age-adjusted reduction in sleep scores in the intervention group compared to the placebo group

 

Table S5: Skin prick test results comparing aeroallergen sensitivity across the trial groups

Aeroallergens

ITT population

 

Placebo

N = 25

Intervention

N = 25

P-value*

 

n (%)

House dust mites (Yes)

Dermatophagoides pteronyssinus

16 (64)

18 (72)

0.544

Dermatophagoides farinae

16 (64)

18 (72)

0.544

Fungal allergens (Yes)

Alternaria

0

2 (8)

0.149

Aspergillus

2 (8)

2 (8)

1

Cladosporium

0

0

Penicillium

0

0

Pollen (Yes)

Grass

12 (48)

12 (48)

1

Tree

3 (8)

8 (32)

0.088

Dander (Yes)

 

 

 

Cat

7 (28)

9 (36)

0.544

Dog

4 (16)

7 (28)

0.306

Hamster

0

0

Feather

0

0

Skin prick tests were carried out for all trial participants at the baseline visit.

ITT: intention to treat; *chi-squared test

 

Graph showing mean RQLQ scores

Figure S1. Mean RQLQ scores of the intervention (A) and placebo (B) groups across time. Each data point represents the mean RQLQ score at the indicated visit.